中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
20期
101-102
,共2页
急性脑卒中%疏血通%胞二磷胆碱%临床疗效
急性腦卒中%疏血通%胞二燐膽堿%臨床療效
급성뇌졸중%소혈통%포이린담감%림상료효
Acute cerebral infarction%Shuxietong%Cytidine diphosphate choline%Clinical curative effect
目的：评价疏血通联合胞二磷胆碱注射液治疗急性脑卒中的临床疗效。方法选择急性脑卒中且不宜溶栓患者42例，随机分为治疗组和对照组，在常规抗血小板聚集、降血压、降血脂等治疗基础上，治疗组以疏血通和胞二磷胆碱注射液静滴14 d；对照组予以丹参注射液和吡拉西坦氯化钠注射液静滴l4 d；观察两组的临床疗效及Glasgow评分、MMSE评分等变化。结果治疗组总有效率95.4%，高于对照组80.0%（P<0.05）。结论疏血通联合胞二磷胆碱注射液治疗急性脑卒中临床疗效肯定，能改善患者意识、智能及预后。
目的：評價疏血通聯閤胞二燐膽堿註射液治療急性腦卒中的臨床療效。方法選擇急性腦卒中且不宜溶栓患者42例，隨機分為治療組和對照組，在常規抗血小闆聚集、降血壓、降血脂等治療基礎上，治療組以疏血通和胞二燐膽堿註射液靜滴14 d；對照組予以丹參註射液和吡拉西坦氯化鈉註射液靜滴l4 d；觀察兩組的臨床療效及Glasgow評分、MMSE評分等變化。結果治療組總有效率95.4%，高于對照組80.0%（P<0.05）。結論疏血通聯閤胞二燐膽堿註射液治療急性腦卒中臨床療效肯定，能改善患者意識、智能及預後。
목적：평개소혈통연합포이린담감주사액치료급성뇌졸중적림상료효。방법선택급성뇌졸중차불의용전환자42례，수궤분위치료조화대조조，재상규항혈소판취집、강혈압、강혈지등치료기출상，치료조이소혈통화포이린담감주사액정적14 d；대조조여이단삼주사액화필랍서탄록화납주사액정적l4 d；관찰량조적림상료효급Glasgow평분、MMSE평분등변화。결과치료조총유효솔95.4%，고우대조조80.0%（P<0.05）。결론소혈통연합포이린담감주사액치료급성뇌졸중림상료효긍정，능개선환자의식、지능급예후。
Objective To evaluate the clinical curative effect of shuxietong joint cytidine diphosphate choline injection in treatment of acute cerebral infarction. Methods Forty patients with acute cerebral infarction were randomly divided into treatment group and control group,in conventional antiplatelet aggregation,fal blood pressure,fal hematic fat,such as treatment of foundation,the treatment group with shuxietong and cytidine diphosphate choline injection static drops of 14 days,the control group and salvia miltiorrhiza injection and pyrazole raschig and sodium chloride injection static drops of l4 days,observed the clinical effects of two groups,glasgow score,MMSE score changes,etc.Results Total effectiveness in treatment group(95.4%)was significantly higher than the control group(80.0%)(P< 0.05).Conclusion Shuxietong cytidine diphosphate choline injection in treatment of acute cerebral infarction clinical curative effect,can significantly improve the patients' consciousness,inteligence and prognosis.
